| |
original article |
Journal |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
International Journal of Pharmaceutical Sciences and Nanotechnology |
2022―Sep―15 |
In-silico Screening of Some Important Bioactive Compounds as Potential Inhibitors of 3CLpro Protein of SARS-CoV-2 and MERS-CoV Virus |
Chandreyi Ghosh, Moumita Saha, Sohini Kulavi, Sirshendu Chatterjee |
| 2 |
[GO] |
International Journal of Pharmaceutical Sciences and Nanotechnology |
2022―Jun―30 |
Black Fungus: Pandemic Devastating India? |
Biswajeet Acharya, Prafulla Kumar Sahu, Gurudutta Pattnaik, Amulyaratna Behera, Santosh Kumar Ranajit, Dinesh Kumar Sharma, Ashish Kumar Meher |
| 3 |
[GO] |
International Journal of Pharmaceutical Sciences and Nanotechnology |
2021―Jun―09 |
Clinical Management Updates for Novel Corona Virus (COVID-19) |
Yogesh Chand Yadav, Ramakant Yadav, Sushant Kumar |
| 4 |
[GO] |
International Journal of Pharmaceutical Sciences and Nanotechnology |
2020―Sep―29 |
Virtual Screening of Natural Compounds to Identify Potential Inhibitors of COVID-19 Protease using Molecular Docking |
Jimish R Patel, Laxman M. Prajapati, Hirak V Joshi, Ujash A Shah |
| 5 |
[GO] |
International Journal of Pharmaceutical Sciences and Nanotechnology |
2020―May―06 |
Scientific and Medical Research on Dr. M.S. Reddy’s Multiple Mixed Strain Probiotic Therapy and its Influence on Assisting to Cure or Prevent the Nosocomial Infections, Synergistically Enhancing the Conventional Cancer Therapies, as an Adjuvant, and its Possible Potential to Prevent or Cure COVID-19 Novel Corona Virus Infection by Balancing the Intestinal Microbiota and Microbiome through Modulation of the Human Immune System |
Malireddy Reddy |
